# Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis

Study · id `cardio:ct-nct07526987` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07526987](<https://clinicaltrials.gov/study/NCT07526987>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07526987

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 934 participants.

## Technical summary

Registry record NCT07526987. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-05 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 934 participants (planned count; ClinicalTrials.gov record NCT07526987, source copy `cardio:ctgov-nct07526987-2026-07-01`, retrieved 2026-10-26)
- Started: 2026-06-05 (actual) (ClinicalTrials.gov record NCT07526987, source copy `cardio:ctgov-nct07526987-2026-07-01`, retrieved 2026-10-26)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07526987, source copy `cardio:ctgov-nct07526987-2026-07-01`, retrieved 2026-10-26)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07526987, source copy `cardio:ctgov-nct07526987-2026-07-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07526987, source copy `cardio:ctgov-nct07526987-2026-07-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07526987-2026-07-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
- Acronym: EMPHASIS-2
- Condition: Ischaemic Stroke
- Intervention (Drug): Minocycline Hydrochloride Capsule (50 mg per capsule)
- Intervention (Drug): Placebo of Minocycline Hydrochloride Capsule (50 mg per capsule, containing 0 mg of minocycline)
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: e9e2aa49c2006d4a99430b228f76cff23c2e28d2ec644728022257062788c13f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
